Addus HomeCare Co. (NASDAQ:ADUS) Shares Acquired by Bokf Na

Bokf Na boosted its holdings in Addus HomeCare Co. (NASDAQ:ADUS) by 7.3% during the fourth quarter, HoldingsChannel reports. The fund owned 4,108 shares of the company’s stock after buying an additional 280 shares during the period. Bokf Na’s holdings in Addus HomeCare were worth $515,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in ADUS. Natixis lifted its stake in shares of Addus HomeCare by 111.9% in the 4th quarter. Natixis now owns 250 shares of the company’s stock valued at $31,000 after purchasing an additional 132 shares during the last quarter. Smartleaf Asset Management LLC lifted its position in Addus HomeCare by 324.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 280 shares of the company’s stock valued at $35,000 after buying an additional 214 shares during the last quarter. Parkside Financial Bank & Trust increased its position in shares of Addus HomeCare by 38.6% during the fourth quarter. Parkside Financial Bank & Trust now owns 531 shares of the company’s stock valued at $67,000 after acquiring an additional 148 shares during the last quarter. Meeder Asset Management Inc. purchased a new stake in shares of Addus HomeCare in the 4th quarter valued at approximately $77,000. Finally, Harvest Fund Management Co. Ltd acquired a new position in shares of Addus HomeCare in the 4th quarter worth approximately $86,000. 95.35% of the stock is currently owned by hedge funds and other institutional investors.

Addus HomeCare Stock Performance

Shares of Addus HomeCare stock opened at $110.91 on Friday. The business has a 50-day simple moving average of $98.86 and a 200-day simple moving average of $114.47. The company has a market cap of $2.04 billion, a PE ratio of 25.38, a P/E/G ratio of 1.41 and a beta of 0.85. Addus HomeCare Co. has a one year low of $88.96 and a one year high of $136.72.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings data on Monday, May 5th. The company reported $1.42 EPS for the quarter, beating analysts’ consensus estimates of $1.33 by $0.09. The company had revenue of $337.71 million for the quarter, compared to the consensus estimate of $341.66 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The company’s quarterly revenue was up 20.3% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.21 EPS. On average, sell-side analysts predict that Addus HomeCare Co. will post 4.59 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several analysts recently weighed in on the stock. Stephens reiterated an “overweight” rating and issued a $142.00 target price on shares of Addus HomeCare in a report on Wednesday, March 12th. StockNews.com lowered Addus HomeCare from a “buy” rating to a “hold” rating in a research note on Wednesday, February 26th. Macquarie lifted their target price on Addus HomeCare from $129.00 to $133.00 and gave the company an “outperform” rating in a research report on Thursday. JMP Securities reissued a “market outperform” rating and set a $150.00 price target on shares of Addus HomeCare in a research report on Tuesday, April 22nd. Finally, Oppenheimer lifted their price objective on shares of Addus HomeCare from $145.00 to $150.00 and gave the company an “outperform” rating in a report on Friday, January 24th. One analyst has rated the stock with a hold rating, six have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Buy” and an average price target of $142.57.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.